BioNTech SE ADR (BNTX) Social Stream
BIONTECH SE (BNTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BNTX.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 6 | $450 | $146 | $275.666 | $154.85 | 78.02% |
| 2021-11-29 | 6 | $450 | $146 | $278.666 | $154.85 | 79.96% |
| 2021-12-15 | 6 | $450 | $146 | $279.555 | $154.85 | 80.53% |
| 2021-12-16 | 7 | $450 | $146 | $281 | $154.85 | 81.47% |
| 2022-01-11 | 7 | $450 | $146 | $281.6 | $154.85 | 81.85% |
| 2022-01-18 | 7 | $450 | $146 | $280.6 | $154.85 | 81.21% |
| 2022-01-26 | 7 | $450 | $146 | $274 | $154.85 | 76.95% |
| 2022-02-14 | 7 | $450 | $146 | $267.3 | $154.85 | 72.62% |
| 2022-03-18 | 7 | $450 | $146 | $264.6 | $154.85 | 70.88% |
| 2022-03-31 | 7 | $450 | $146 | $271.5 | $154.85 | 75.33% |
| 2022-04-05 | 7 | $339 | $146 | $247.1 | $154.85 | 59.57% |
| 2022-04-12 | 7 | $339 | $146 | $245.1 | $154.85 | 58.28% |
| 2022-05-10 | 7 | $300 | $146 | $240.9 | $154.85 | 55.57% |
| 2022-05-18 | 8 | $300 | $146 | $240.7 | $154.85 | 55.44% |
| 2022-05-24 | 9 | $350 | $146 | $246.916 | $154.85 | 59.45% |
| 2022-06-21 | 9 | $350 | $183 | $256.09 | $154.85 | 65.38% |
| 2022-07-15 | 10 | $350 | $183 | $240.7 | $154.85 | 55.44% |
| 2022-07-29 | 10 | $350 | $183 | $240.8 | $154.85 | 55.51% |
| 2022-08-08 | 10 | $350 | $192 | $247.222 | $154.85 | 59.65% |
| 2022-08-09 | 10 | $350 | $194 | $246.444 | $154.85 | 59.15% |
| 2022-08-13 | 10 | $350 | $194 | $245.222 | $154.85 | 58.36% |
| 2022-08-18 | 11 | $350 | $177 | $238.4 | $154.85 | 53.96% |
| 2022-09-17 | 10 | $350 | $177 | $226.7 | $154.85 | 46.4% |
| 2022-10-03 | 10 | $350 | $153 | $224.3 | $154.85 | 44.85% |
| 2022-10-12 | 9 | $350 | $153 | $224.3 | $154.85 | 44.85% |
| 2022-10-21 | 9 | $350 | $153 | $224 | $154.85 | 44.66% |
| 2022-11-07 | 9 | $350 | $132 | $218.9 | $154.85 | 41.36% |
| 2022-11-08 | 9 | $350 | $132 | $216 | $154.85 | 39.49% |
| 2022-11-21 | 9 | $350 | $148 | $217.6 | $154.85 | 40.52% |
The Trend in the Analyst Price Target
BNTX's average price target has moved up $171.83 over the prior 31 months.
BNTX reports an average of 50.33% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-01 | 7 | 450 | 146 | 267.300 | 179.60 | 48.83% |
| 2022-03-31 | 7 | 450 | 146 | 271.500 | 170.56 | 59.18% |
| 2022-05-24 | 9 | 350 | 183 | 256.090 | 154.50 | 65.75% |
| 2022-07-29 | 9 | 350 | 192 | 247.222 | 165.15 | 49.7% |
| 2022-11-21 | 9 | 350 | 148 | 217.600 | 158.41 | 37.37% |
BNTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.11 | 4 | 0 | 5 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
BNTX's average broker recommendation rating worsened by 0.11 over the prior 32 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how BIONTECH SE fares relative to all US stocks, note that its average analyst price target is greater than 3504.13% of that group.
- BIONTECH SE's variance in analysts' estimates is lower than -3057.39% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of stocks in the large market cap category, BIONTECH SE's number of analysts covering the stock is higher than 870.61% of them.
- In terms of how BIONTECH SE fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 1028.92% of that group.
In the Pharmaceutical Products industry, MRNA, GILD, and BIIB are the three stocks most similar to BIONTECH SE regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding BNTX using the data that counts. Try POWR Ratings for free.